[go: up one dir, main page]

IL196381A0 - Anti-cancer therapy comprising an h2-blocker, at least one antiinflammatory agent and a cytotoxic agent - Google Patents

Anti-cancer therapy comprising an h2-blocker, at least one antiinflammatory agent and a cytotoxic agent

Info

Publication number
IL196381A0
IL196381A0 IL196381A IL19638109A IL196381A0 IL 196381 A0 IL196381 A0 IL 196381A0 IL 196381 A IL196381 A IL 196381A IL 19638109 A IL19638109 A IL 19638109A IL 196381 A0 IL196381 A0 IL 196381A0
Authority
IL
Israel
Prior art keywords
agent
blocker
cancer therapy
antiinflammatory
cytotoxic agent
Prior art date
Application number
IL196381A
Other versions
IL196381A (en
Original Assignee
Tiltan Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IL2007/000836 external-priority patent/WO2008004231A1/en
Application filed by Tiltan Pharma Ltd filed Critical Tiltan Pharma Ltd
Priority to IL196381A priority Critical patent/IL196381A/en
Publication of IL196381A0 publication Critical patent/IL196381A0/en
Publication of IL196381A publication Critical patent/IL196381A/en

Links

IL196381A 2006-07-07 2009-01-07 Anti-cancer therapeutic composition and kit comprising an h2-blocker, at least one antiinflammatory agent and a cytotoxic agent IL196381A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL196381A IL196381A (en) 2006-07-07 2009-01-07 Anti-cancer therapeutic composition and kit comprising an h2-blocker, at least one antiinflammatory agent and a cytotoxic agent

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US81916406P 2006-07-07 2006-07-07
US88010707P 2007-01-12 2007-01-12
PCT/IL2007/000836 WO2008004231A1 (en) 2006-07-07 2007-07-04 Anti-cancer therapy comprising an h2-blocker, at least one antiinflammatory agent and a cytotoxic agent
IL196381A IL196381A (en) 2006-07-07 2009-01-07 Anti-cancer therapeutic composition and kit comprising an h2-blocker, at least one antiinflammatory agent and a cytotoxic agent

Publications (2)

Publication Number Publication Date
IL196381A0 true IL196381A0 (en) 2009-09-22
IL196381A IL196381A (en) 2012-05-31

Family

ID=42113377

Family Applications (1)

Application Number Title Priority Date Filing Date
IL196381A IL196381A (en) 2006-07-07 2009-01-07 Anti-cancer therapeutic composition and kit comprising an h2-blocker, at least one antiinflammatory agent and a cytotoxic agent

Country Status (1)

Country Link
IL (1) IL196381A (en)

Also Published As

Publication number Publication date
IL196381A (en) 2012-05-31

Similar Documents

Publication Publication Date Title
IL198911A0 (en) Drug delivery
IL196559A0 (en) Combination therapy
IL194751A0 (en) Drugs and uses
GB0608928D0 (en) Therapeutic agents
GB0601962D0 (en) Therapeutic agents
IL196556A0 (en) Combination therapy
EP2054061A4 (en) Combination therapy
ZA201001418B (en) Cdh3 pepetide and medicinal agent comprising the same
ZA200806318B (en) Drug combinations
GB0616214D0 (en) Therapeutic Agents
EP2025667A4 (en) 9,10-secopregnane derivative and pharmaceutical
ZA200902203B (en) Combination therapy
IL197883A0 (en) Combination drug
GB0611152D0 (en) Therapeutic agents
EP2005964A4 (en) The medicament for treating hyperphospheremia and preparation thereof
GB0625783D0 (en) Medicament
IL191892A0 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
IL195618A0 (en) Drug administration methods
GB0609676D0 (en) Therapeutic agents
IL196381A0 (en) Anti-cancer therapy comprising an h2-blocker, at least one antiinflammatory agent and a cytotoxic agent
GB0613031D0 (en) Medicaments
IL180305A0 (en) Administration set with two keys
GB0615064D0 (en) Medicament
ZA201005396B (en) 17-hydroxy-19-nor-21-carboxylic acid-steroid y-lactone derivative,use thereof,and medicament containing the derivative
GB0601818D0 (en) Therapeutic agent

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees